Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.
about
The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) PhenotypePrognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors.Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based studyPHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors.Update on pancreatic neuroendocrine tumors.Pancreatic Neuroendocrine Tumors: an Update.von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms.Endoscopic ultrasound-guided ethanol ablation of pancreatic neuroendocrine tumours: A case study and literature review.Pharmacotherapy of Zollinger-Ellison syndrome.Altered PTEN, ATRX, CHGA, CHGB, and TP53 expression are associated with aggressive VHL-associated pancreatic neuroendocrine tumors.Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors.ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic CharacteristicsTherapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesRSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors.Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.Everolimus for the treatment of pancreatic neuroendocrine tumors.Current understanding of the molecular biology of pancreatic neuroendocrine tumors.Advancements in pancreatic neuroendocrine tumors.Translational research in endocrine surgery.Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets.The genetic classification of pancreatic neoplasia.Molecular pathogenesis and targeted therapy of sporadic pancreatic neuroendocrine tumors.Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors.Spatial intratumoral heterogeneity of proliferation in immunohistochemical images of solid tumors.Translational research in neuroendocrine tumors: pitfalls and opportunities.Duodenal and Ampullary Carcinoid Tumors: Size Predicts Necessity for Lymphadenectomy.DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors.Sunitinib is effective and tolerable in Chinese patients with advanced pancreatic neuroendocrine tumors: a multicenter retrospective study in China.
P2860
Q28071562-0921EF95-788B-42B6-A206-5C1C2BC866C1Q33708663-25D5CD9C-C7BE-472F-BFEB-4934DBA4063AQ33743715-F32B8FE6-8370-4D5B-BD8C-BBBA319FB53FQ33767655-A0A9A9E4-6DB8-42A9-878F-E0F8CC1E0D2FQ34453043-8CE4575D-F4CE-49CD-BC5D-B2836EA286CDQ36400062-B5828C75-ED69-4168-8A7E-9EA29A1A0125Q36409660-CEF33F42-250E-4EE4-ABB6-C5263459A95FQ36526246-498F9A79-E515-4107-BE92-716174D23E6CQ36632665-86E996CE-AF8B-48F4-B2B8-15CB13D7F452Q36815312-02D59311-F91B-46ED-AAE8-AC5E5B0AB10EQ36843996-DC0021DB-179E-40D5-BD9A-BD59DECACFB4Q36849357-14B9C248-C7C5-4E7F-9E97-F3C14B3F6D84Q37097257-39B44A2C-A0C3-42FB-BDF6-88C585268DE4Q37125550-436FB6E1-0383-4FEB-87E2-4620E0A7965FQ37628945-BFED19EA-53C1-401D-A889-85DD21CCA726Q37631597-2F3E378D-E478-4E80-949D-B6035B283CFFQ38032923-29510FE6-A3B6-4BA7-85CA-626E169547A1Q38120515-4E3E1A5D-3501-4075-973E-D9403FF0C4ABQ38125257-A08C13B8-CDAD-4A87-9BAC-15E12F13D153Q38135137-D82CCCDF-B037-44C6-A202-0D9707E9E597Q38174516-8E64127E-4282-4770-8882-43FDD2DDDA69Q38326191-0AE6E8B4-5393-4050-AD75-B2BBE41AC0A3Q38331666-918C7558-4C8E-437B-BE20-61480D69C54DQ38581192-C24D11AB-FF68-4D50-B855-E056BCB150CAQ38856277-AE8F7FEA-3EFB-4CF1-8740-62BB1B2AD9EBQ38958002-76B9FD66-AD54-4AC0-AEDD-01FC245F2A40Q39314175-81795A93-31D3-40D9-A34F-578B655908F7Q41472752-FEC73AA5-5DD3-4F16-8334-025446A08D07Q50529718-4CD96AC7-9FCF-4FA1-936A-1A137A53B712
P2860
Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.
@en
Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.
@nl
type
label
Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.
@en
Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.
@nl
prefLabel
Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.
@en
Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.
@nl
P2093
P2860
P356
P1476
Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.
@en
P2093
Anirban Maitra
Barish H Edil
Roeland F de Wilde
P2860
P2888
P304
P356
10.1038/NRGASTRO.2012.9
P407
P577
2012-02-07T00:00:00Z